"approved"@en . . . . . . . . . "Piperacilina"@en . . . . . . "(2S,5R,6R)-6-{[(2R)-2-{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid"@en . . . " "@en . . . . "36-72 minutes"@en . . . . . . . . . . "Piperacillina"@en . . "Bruce E. Haeger, \"Composition of matter comprising a low bulk density lyophilized preparation of Sodium Piperacillin.\" U.S. Patent US4534977, issued October, 1984."@en . . "* 101 mL/kg [intravenous administration of 50 mg/kg (5-minute infusion) in neonates]"@en . "* 32\u00A0-\u00A041 mL/min/1.73\u00A0m2 * 124\u00A0-\u00A0160 mL/min/1.73\u00A0m2 [older pediatric patients]"@en . "Piperacillin"@en . . . . . . "Piperacillin Anhydrous"@en . "Piperacillin"@en . . . . "Piperacillinum"@en . . " "@en . . . "# Lau WK, Mercer D, Itani KM, Nicolau DP, Kuti JL, Mansfield D, Dana A: Randomized, open-label, comparative study of piperacillin-tazobactam administered by continuous infusion versus intermittent infusion for treatment of hospitalized patients with complicated intra-abdominal infection. Antimicrob Agents Chemother. 2006 Nov;50(11):3556-61. Epub 2006 Aug 28. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16940077"@en . . "As with other penicillins, PIPRACIL is eliminated primarily by glomerular filtration and tubular secretion; it is excreted rapidly as unchanged drug in high concentrations in the urine. Because PIPRACIL is excreted by the biliary route as well as by the renal route, it can be used safely in appropriate dosage in patients with severely restricted kidney function."@en . . . "66258-76-2"@en . . . . . . . . "Not absorbed following oral administration."@en . "By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, Piperacillin inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that Piperacillin interferes with an autolysin inhibitor."@en . . . . "Enteric bacteria and other eubacteria"@en . . "Semisynthetic, broad-spectrum, ampicillin derived ureidopenicillin antibiotic proposed for pseudomonas infections. It is also used in combination with other antibiotics. [PubChem]"@en . . . . . . "Pip\u00E9racilline"@en . . . . . "For the treatment of polymicrobial infections."@en . .